Combination of serological and cytokine release assays for improved diagnosis of childhood tuberculosis in Zambia (PROMISE-TB).

Autor: Tuaillon E; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France; University Hospital of Montpellier, Montpellier, France. Electronic address: e-tuaillon@chu-montpellier.fr., Mwyia M; Pediatric Center of Excellence, University Teaching Hospital, Lusaka, Zambia., Bollore K; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France., Pisoni A; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France; University Hospital of Montpellier, Montpellier, France., Rubbo PA; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France; University Hospital of Montpellier, Montpellier, France., Richard M; Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France., Kremer L; Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France., Tonga MMW; Pediatric Center of Excellence, University Teaching Hospital, Lusaka, Zambia., Chanda D; Pediatric Center of Excellence, University Teaching Hospital, Lusaka, Zambia., Peries M; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France., Vallo R; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France., Eymard-Duvernay S; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France., D'Ottavi M; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France., Kankasa C; Pediatric Center of Excellence, University Teaching Hospital, Lusaka, Zambia., de Perre PV; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France; University Hospital of Montpellier, Montpellier, France., Moles JP; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France., Nagot N; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, Inserm, Etablissement Français du Sang, Université des Antilles, Montpellier, France; University Hospital of Montpellier, Montpellier, France.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Nov; Vol. 148, pp. 107248. Date of Electronic Publication: 2024 Sep 26.

Clinical performance and application of novel serum collection "Ser-Col" device in the practice of laboratory diagnosis of infection diseases and several other immunochemical tests.

Autor: Harutyunyan H; Neuroscience Laboratory, Cobrain Center, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia., Hovhannisyan A; Department of Infectious Diseases, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia., Torosyan H; Neuroscience Laboratory, Cobrain Center, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia., Hakobjanyan G; Laboratory-Diagnostic Center of Heratsi Clinical Hospital, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia., Grigoryan A; Neuroscience Laboratory, Cobrain Center, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia., Petrosyan G; Laboratory-Diagnostic Center of Heratsi Clinical Hospital, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia., Movsisyan M; Neuroscience Laboratory, Cobrain Center, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia; Department of Allergology and Clinical Immunology, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia., Poland D; Labonovum, Limmen, the Netherlands., Monkel R; Labonovum, Limmen, the Netherlands., Lommen J; Labonovum, Limmen, the Netherlands., Tuaillon E; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, Établissement Français du Sang, Antilles University, Montpellier University Hospital, Montpellier, France., Yenkoyan K; Neuroscience Laboratory, Cobrain Center, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia; Department of Biochemistry, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia. Electronic address: konstantin.yenkoyan@meduni.am.

Publikováno v: Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2025 Jan 15; Vol. 565, pp. 119970. Date of Electronic Publication: 2024 Sep 21.

Development and field evaluation in African and Asian countries of an hepatitis B virus PCR on open polyvalent platforms to determine treatment eligibility: results from the "Agence Nationale de Recherche sur le Sida et les hépatites" 12327 study.

Autor: Kania D; Department of Biomedical Sciences, Laboratoire de Virologie, Centre Muraz, Bobo-Dioulasso, Burkina Faso., Nouhin J; Virology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia., Bolloré K; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, INSERM, EFS, Université des Antilles, Montpellier, France., Njouom R; Virology Unit, Centre Pasteur of Cameroon, Yaounde, Cameroon., Toni TD; CeDReS, CHU de Treichville, Abidjan, Cote d'Ivoire., Maiga AI; University Research and Clinical Center, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Toure-Kane C; Laboratoire de Bactériologie-Virologie, CHU Aristide le Dantec, Dakar, Senegal., Ngo-Giang-Huong N; MIVEGEC UMR IRD224-CNRS5290, Institut de Recherche pour le Développement (the French National Research Institute for Sustainable Development), Montpellier, France; LMI PRESTO, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand., Dagnra A; Centre National de Référence VIH-IST/PNLS, BIOLIM, FMMP/UL, Lomé, Togo., Chuong Le DH; Department of Biomedical, Food Analysis and Health Service, Ho Chi Minh City Pasteur Institute, Ho Chi Minh City, Viet Nam., Lunel-Fabiani F; Laboratory of Virology, University Hospital & LUNAM University and HIFIH Laboratory, UPRES EA 3859, Angers, France., Castera-Guy J; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, INSERM, EFS, Université des Antilles, Montpellier, France., Rubbo PA; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, INSERM, EFS, Université des Antilles, Montpellier, France; Omunis, Montpellier, France., Pisoni A; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, INSERM, EFS, Université des Antilles, Montpellier, France; Department of Virology, CHU de Montpellier, Montpellier, France., Plantier JC; Laboratoire de Virologie, CHU Charles Nicolle, Rouen, France., Tuaillon E; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, INSERM, EFS, Université des Antilles, Montpellier, France; Department of Virology, CHU de Montpellier, Montpellier, France. Electronic address: e-tuaillon@chu-montpellier.fr.

Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Aug; Vol. 30 (8), pp. 1067-1073. Date of Electronic Publication: 2024 May 11.

SARS-CoV-2 nucleocapsid antigen in plasma of children hospitalized for COVID-19 or with incidental detection of SARS-CoV-2 infection.

Autor: Capelli N; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, Établissement Français du Sang, Montpellier, France.; Department of Virology, Montpellier University Hospital, Montpellier, France., Domitien Payet L; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, Établissement Français du Sang, Montpellier, France.; Department of Virology, Montpellier University Hospital, Montpellier, France., Alcocer Cordellat C; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, Établissement Français du Sang, Montpellier, France.; Department of Virology, Montpellier University Hospital, Montpellier, France., Pisoni A; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, Établissement Français du Sang, Montpellier, France.; Department of Virology, Montpellier University Hospital, Montpellier, France., Engelmann I; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, Établissement Français du Sang, Montpellier, France.; Department of Virology, Montpellier University Hospital, Montpellier, France., Van de Perre P; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, Établissement Français du Sang, Montpellier, France.; Department of Virology, Montpellier University Hospital, Montpellier, France., Jeziorski E; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, Établissement Français du Sang, Montpellier, France.; Department of General Pediatrics, Infectiology and Clinical Immunology, CEREMIA, Montpellier University Hospital, Montpellier, France., Tuaillon E; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, Établissement Français du Sang, Montpellier, France.; Department of Virology, Montpellier University Hospital, Montpellier, France.

Publikováno v: Journal of medical virology [J Med Virol] 2024 Jan; Vol. 96 (1), pp. e29358.

Staging of recent HIV-1 infection using Geenius rapid confirmatory assay compared to INNO-LIA, New Lav and Blot 2.2 assays

Autor: Tuaillon, E., Sanosyan, A., Pisoni, A., Liscouët, J., Makinson, A., Perre, P.Van de

Publikováno v: In Journal of Clinical Virology October 2017 95:47-51